New therapeutic targets in CLL: ROR1

The identification of novel therapeutic targets is essential for the improved treatment of hematological cancer, particularly due to the development of drug resistance. Here, Constantine Tam, MD, FRAC... Author: VJHemOnc Added: 02/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts